$135 Million is the total value of M28 Capital Management LP's 11 reported holdings in Q1 2024. The portfolio turnover from Q4 2023 to Q1 2024 was 10.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WVE | Sell | WAVE LIFE SCIENCES LTD | $43,190,000 | +16.0% | 7,000,000 | -5.1% | 31.91% | +3.5% |
| INVIVYD INC | $41,062,230 | +12.7% | 9,248,250 | 0.0% | 30.34% | +0.5% | ||
| New | FRACTYL HEALTH INC | $13,735,266 | – | 1,856,117 | +100.0% | 10.15% | – | |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $10,390,219 | -33.7% | 385,680 | -26.3% | 7.68% | -40.9% |
| SLN | Sell | SILENCE THERAPEUTICS PLCads | $6,467,040 | +2.3% | 299,400 | -17.7% | 4.78% | -8.7% |
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $5,433,888 | +4.3% | 110,400 | -22.7% | 4.02% | -7.0% |
| CURIS INC | $4,586,607 | -14.7% | 421,951 | 0.0% | 3.39% | -24.0% | ||
| BBIO | BRIDGEBIO PHARMA INC | $3,747,504 | -23.4% | 121,200 | 0.0% | 2.77% | -31.7% | |
| TGTX | Sell | TG THERAPEUTICS INC | $2,457,936 | -33.6% | 161,600 | -25.4% | 1.82% | -40.8% |
| PRQR | Sell | PROQR THRAPEUTICS N V | $2,334,548 | -38.3% | 1,019,498 | -46.6% | 1.72% | -45.0% |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | $1,927,640 | -6.5% | 67,400 | 0.0% | 1.42% | -16.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-05-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| WAVE LIFE SCIENCES LTD | 11 | Q2 2024 | 46.4% |
| INVIVYD INC | 11 | Q2 2024 | 32.1% |
| ROCKET PHARMACEUTICALS INC | 11 | Q2 2024 | 16.6% |
| BRIDGEBIO PHARMA INC | 11 | Q2 2024 | 6.1% |
| TG THERAPEUTICS INC | 11 | Q2 2024 | 9.2% |
| PROQR THRAPEUTICS N V | 10 | Q2 2024 | 6.7% |
| NEXIMMUNE INC | 8 | Q3 2023 | 0.5% |
| STOKE THERAPEUTICS INC | 7 | Q2 2023 | 10.2% |
| CURIS INC | 7 | Q2 2023 | 9.7% |
| SPRINGWORKS THERAPEUTICS INC | 7 | Q2 2024 | 6.8% |
View M28 Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CURIS INC | February 12, 2024 | 421,951 | 7.2% |
| Wave Life Sciences Ltd. | February 12, 2024 | 7,373,413 | 6.0% |
| Adagio Therapeutics, Inc. | August 19, 2022 | 9,248,250 | 8.5% |
View M28 Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-13 |
| 4 | 2024-05-23 |
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G | 2024-02-12 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 13F-HR | 2023-11-13 |
View M28 Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.